The SGLT2 inhibitor era: what more can we expect?
Topic:
Diabetes and the Heart
Speaker:
Professor S. Anker (Berlin, DE)
Sponsored by The Boehringer Ingelheim, Eli Lilly and Company Alliance
Event:
ESC Congress 2019
Congress Presentation
About the speaker
Professor Stefan Anker
Charite University Hospital, Berlin (Germany)
171
presentations
10
followers
4 more presentations in this session
Welcome and introduction
Speaker: Professor T. Luscher (London, GB)
The role of SGLT2 inhibitors in CV risk reduction in patients with type 2 diabetes
Speaker: Professor S. Kaul (Los Angeles, US)
Taking the initiative: the cardiologist´s perspective
Speaker: Professor N. Marx (Aachen, DE)
Audience questions and answers, summary and close
Speaker: Professor T. Luscher (London, GB)
Access the full session
SGLT2 inhibitors in clinical cardiology: modern-day cardiovascular management in patients with type 2 diabetes
Speakers:
Professor S. Anker, Professor T. Luscher, Professor S. Kaul, Professor N. Marx, Professor T. Luscher
About the event
